An FDA reform agenda: What would Commissioner Scott Gottlieb do in his first six months?
An accelerated approval pathway for complex generics, embracing killer apps, publishing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
